Yang Xiang to Retrospective Studies
This is a "connection" page, showing publications Yang Xiang has written about Retrospective Studies.
Connection Strength
0.765
-
He SQ, Liu GY, Yu YH, Wang L, Zhang GY, Peng DS, Bei WX, Chen CL, Lv SH, Zhao ZY, Huang Y, Xiang YQ. Efficacy of local-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy: A multicenter, propensity score matching study. Radiother Oncol. 2025 02; 203:110687.
Score: 0.094
-
He SQ, Liu GY, Yu YH, Wang L, Zhang GY, Peng DS, Bei WX, Chen CL, Lv SH, Zhao ZY, Huang Y, Xiang YQ. Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients receiving immuno-chemotherapy: A multicenter, retrospective cohort study. Oral Oncol. 2024 Dec; 159:107074.
Score: 0.093
-
Liu GY, Li Z, Chen XX, Xia WX, Yao HR, Xiang YQ. Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis. Head Neck. 2023 10; 45(10):2571-2579.
Score: 0.086
-
Wang D, Jia C, Cheng H, Cao D, Shen K, Yang J, Xiang Y. Analysis of Outcomes and Prognostic Factors after Fertility-Sparing Surgery in Patients with Early Stage Juvenile Granulosa Cell Tumor of the Ovary: Experience from a Tertiary Center. J Pediatr Adolesc Gynecol. 2022 Aug; 35(4):486-491.
Score: 0.076
-
Xiang ZF, Hu DF, Xiong HC, Li MY, Zhang ZC, Shen ED, Li WZ, Xiang YQ. Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database. Oral Oncol. 2021 06; 117:105284.
Score: 0.073
-
Liu Q, Wei JN, Zhou JY, Zhang CR, Ke LR, Lu N, Deng Y, Kuang YW, Hua YC, Wang MW, Gong J, Dong SH, Wu L, Lv X, Xiang YQ, Guo X, Xia WX. Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma. Oral Oncol. 2026 Feb; 173:107825.
Score: 0.025
-
He SQ, Huang Y, Zhao ZY, Wen SQ, Lv SH, Wang L, Bei WX, Xiang YQ, Liu GY. Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study. Br J Cancer. 2026 Feb; 134(4):598-607.
Score: 0.025
-
He SQ, Lv SH, Wen SQ, Wang L, Yu YH, Zhang GY, Peng DS, Bei WX, Chen CL, Zhao ZY, Huang Y, Xiang YQ, Liu GY. Efficacy of metastasis-directed therapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy and local regional radiotherapy: a multicenter retrospective study. BMC Cancer. 2025 Dec 02; 25(1):1847.
Score: 0.025
-
Gao Y, Du C, Xu Y, Cheng X, Zhao H, Jiang F, Cheng N, Xiang Y, Zhang Y, Li Y, Liu H, Chai X, Lian X, Zhao W, Li N. Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study. J Clin Endocrinol Metab. 2025 Nov 18; 110(12):3342-3353.
Score: 0.025
-
He SQ, Lv SH, Wen SQ, Yu YH, Zhang GY, Peng DS, Bei WX, Chen CL, Zhao ZY, Huang Y, Xiang YQ, Liu GY. Efficacy of metastatic lesion radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving local regional radiotherapy and chemo-immunotherapy: a multicenter retrospective study. Radiother Oncol. 2025 12; 213:111160.
Score: 0.025
-
Gui T, Cao D, Yang J, Wei Z, Xie J, Wang W, Xiang Y, Peng P. Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches. J Gynecol Oncol. 2025 07; 36(4):e53.
Score: 0.024
-
Wang W, Kong Y, Li Y, Wan X, Feng F, Ren T, Zhao J, Xiang Y, Yang J. Pulmonary resection of residual lesions of pulmonary metastasis from gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2023 09 04; 33(9):1376-1382.
Score: 0.022
-
Liu GY, Lu N, Bei WX, Li WZ, Liang H, Xia WX, Xiang YQ, Yao HR. Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor. Front Immunol. 2023; 14:1069010.
Score: 0.021
-
Jiang F, Lin JK, Xiang Y, Xu ZF, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study. Eur J Cancer. 2022 01; 161:119-127.
Score: 0.019
-
Zheng H, Gao Y, Guo H, Li L, Li Q, Cui H, Lin A, Sun L, Hu Y, Kang S, Duan W, Pan L, Wang S, Yang Y, Li Y, Kong W, Xiang Y, Tian X, Ling B, Ha C, Bai W. Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study. Mol Cancer Ther. 2021 09; 20(9):1735-1742.
Score: 0.018
-
Li WZ, Liu GY, Lin LF, Lv SH, Qiang MY, Lv X, Wu YS, Liang H, Ke LR, Wang DL, Yu YH, Qiu WZ, Liu KY, Guo X, Li JP, Zou YJ, Xiang YQ, Xia WX. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it. Radiother Oncol. 2020 04; 145:101-108.
Score: 0.017
-
Ran Q, Jin F, Xiang Y, Xiang L, Wang Q, Li F, Chen L, Zhang Y, Wu C, Zhou L, Xiao Y, Chen L, Wu J, Zhong JF, Li SC, Li Z. CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma. Proc Natl Acad Sci U S A. 2019 10 08; 116(41):20511-20516.
Score: 0.016
-
Liu GY, Lv X, Wu YS, Mao MJ, Ye YF, Yu YH, Liang H, Yang J, Ke LR, Qiu WZ, Huang XJ, Li WZ, Guo X, Xiang YQ, Xia WX. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis. Cancer Commun (Lond). 2018 05 10; 38(1):21.
Score: 0.015
-
Qiu WZ, Ke LR, Xia WX, Yang J, Yu YH, Liang H, Huang XJ, Liu GY, Li WZ, Xiang YQ, Guo X, Lv X. A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy. PLoS One. 2017; 12(8):e0182963.
Score: 0.014
-
Zeng Q, Wang J, Lv X, Li J, Yin LJ, Xiang YQ, Guo X. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis. BMC Cancer. 2016 08 30; 16:693.
Score: 0.013
-
Guo SS, Tang LQ, Chen QY, Zhang L, Liu LT, Guo L, Mo HY, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Wang L, Lv X, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA =4000 copies/ml: a matched study. Oncotarget. 2016 May 17; 7(20):29739-48.
Score: 0.013
-
Guo SS, Tang LQ, Zhang L, Chen QY, Liu LT, Guo L, Mo HY, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Wang L, Lv X, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ. The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy. BMC Cancer. 2015 Dec 16; 15:977.
Score: 0.013
-
Tang LQ, Li CF, Li J, Chen WH, Chen QY, Yuan LX, Lai XP, He Y, Xu YX, Hu DP, Wen SH, Peng YT, Zhang L, Guo SS, Liu LT, Guo L, Wu YS, Luo DH, Huang PY, Mo HY, Xiang YQ, Sun R, Chen MY, Hua YJ, Lv X, Wang L, Zhao C, Cao KJ, Qian CN, Guo X, Zeng YX, Mai HQ, Zeng MS. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma. J Natl Cancer Inst. 2016 Jan; 108(1).
Score: 0.012